Approval · Notice of Compliance 37626 · 2026
CONTINGENCY ONE: Notice of Compliance 37626
Issued May 29, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37626
- Date
- May 29, 2026
- Company
- Senador Laboratories Private LimitedHyderabad, Telangana, India
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CONTINGENCY ONE | 02425009 | Marketed |
Medicinal ingredients
- LEVONORGESTREL 1.5 MG per TAB